ABSTRACT
Objective Model the effect of partial and full reversal of containment measures on COVID-19 morbidity and mortality in Ecuador.
Methods Susceptible, Infected, Recovered (SIR) models were used to simulate the transmission dynamics of COVID-19 before and after the implementation (and reversal) of containment measures. A Healthcare Compartmental Epidemic Model (HeCEM), which accounts for Hospital and Intensive Care Unit admission rates, was developed to also simulate the effect of reversing social distancing containment measures. Reported COVID-19 cases between February 29th and April 23rd, 2020 were obtained from the Servicio Nacional de Gestión de Riesgos y Emergencia, Ecuador’s national emergency management office. An ARIMA model was used to forecast reported number of cases based on the reported number of cases. SIR, HeCEM, and ARIMA model prediction errors were estimated.
Results SIR and HeCEM models predict that, at the moment, hospital and ICU bed needs for COVID-19 patients exceed the capacity in Ecuador. Partial or full reversal of containment measures before reaching the point where hospital and ICU beds are enough to meet the expected demand will result in secondary waves that delay reaching this equilibrium, resulting in thousands of excess deaths. Forecasts predict over 50,000 reported COVID-19 cases by July 25th, 2020.
Conclusion Partial reversal of containment measures should occur only after enough hospital and beds are available to meet the demand.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Nothing to report
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional IRB at USF
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Publicly available as cited.